Alkem Laboratories launches awareness initiative ‘Stop Sneeze to Wheeze’
To raise awareness about coexistence of allergic rhinitis and asthma during World Allergy Week 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
allergic rhinitis
Glenmark and Lotus enter into partnership for Ryaltris in key South East Asian markets
Glenmark will be responsible for the manufacturing and supply of Ryaltris, while Lotus International will be responsible for the…
Glenmark launches Ryaltris-AZ in India
It has been launched at a price of Rs 175/- per pack of 75 metered doses
Glenmark’s Ryaltris nasal spray gets approval in Europe for treatment of allergic rhinitis
It is a novel fixed-dose combination nasal spray of an anti-histamine and a steroid, indicated for the treatment of symptoms…
Glenmark, Bausch Health partner to commercialise RYALTRIS nasal spray in Canada
RYALTRIS is currently under review by Health Canada with a proposed indication for the treatment of seasonal allergic rhinitis in…
Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia
It is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age
JB Chemicals gets ANDA approval from US FDA for Loratadine Tablets
The tablets are indicated for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for OTC use
Lupin opens centre of excellence for inhalation research in Florida
The new facility will focus on the R&D of inhalation products for the treatment of asthma, allergic rhinitis, chronic…